Ipca Laboratories Community
Our community narratives are driven by numbers and valuation.
Value any stock for free in seconds
Get alerts and valuation updates
Participate in discussions
WA
Consensus Narrative from 19 Analysts
Synergies With Unichem Laboratories And US Market Re-entry Will Boost Future Earnings
Key Takeaways Strong domestic formulation growth and market share improvement position Ipca Laboratories for increased revenues and earnings. Synergies with Unichem Labs and U.S. market re-entry expected to boost margins and revenue.
View narrative₹1.56k
FV
0.4% undervalued intrinsic discount12.11%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
5 days ago author updated this narrative